News Headlines Article

F.D.A. Vote Is Minor Victory for Troubled Diabetes Drug
New York Times

A panel of experts voted Thursday to loosen restrictions on a controversial diabetes drug, saying doctors should have more freedom to prescribe it to patients. But the decision was unlikely to improve prospects for the drug; sales have sagged since a highly publicized episode in 2007, when a doctor showed evidence that it increased the risk of heart problems.

Thirteen members of a 26-member Food and Drug Administration advisory committee voted to soften the restrictions on the drug, Avandia, which has gone from being one of the industry’s biggest blockbusters to a marginalized drug used by a few thousand people.